EP Life Sciences L.P. is a private investment fund based in New York, New York. According to its most recent Form D, filed May 14, 2026, it has sold $507,821,582 of interests to 170 investors since its first sale in Jul 2018. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Patrick Shaw; Andrew Sommers; Joel Ehrenkranz.
- Total raised
- $507,821,582Cumulative sales reported on Form D
- Investors
- 170
- First sale
- Jul 1, 2018
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Patrick Shaw; Andrew Sommers; Joel Ehrenkranz
- Latest Form D
- May 14, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about EP Life Sciences L.P.
What is the minimum investment for EP Life Sciences L.P.?
EP Life Sciences L.P.'s latest Form D, filed May 14, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in EP Life Sciences L.P.?
EP Life Sciences L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has EP Life Sciences L.P. raised?
EP Life Sciences L.P. reports $507,821,582 sold from 170 investors on its Form D filed May 14, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is EP Life Sciences L.P. based?
EP Life Sciences L.P. is based in New York, New York.
When did EP Life Sciences L.P. launch?
EP Life Sciences L.P. reports its first sale in Jul 2018.
Size compared with every private investment fund
Raised more than 88% of the 2,822 private investment funds based in New York, and more than 88% of all 10,255 that report sales.